Insider Trading & Ownership - Levitsky Hyam

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Levitsky Hyam

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-01
Option Award
2024-04-03
8:00 pm
N/A
2034-04-01
Replimune Group Inc. REPL Levitsky Hyam
Director
32,000 $0 32,000
(Direct)
View
2024-03-07
Option Award
2024-03-11
7:34 pm
N/A
2034-03-07
Century Therapeutics Inc. IPSC Levitsky Hyam
President of R&D
170,000 $0 706,544
(Direct)
View
2023-04-12
Option Award
2023-04-14
7:56 pm
N/A
2033-04-12
Century Therapeutics Inc. IPSC Levitsky Hyam
President of R&D
131,250 $0 131,250
(Direct)
View

Ownership
2023-04-14
7:55 pm
N/A
N/A
Century Therapeutics Inc. IPSC Levitsky Hyam
President of R&D
0 $0 570,660
(Indirect)
View
2023-04-01
Option Award
2023-04-04
8:03 pm
N/A
2033-04-01
Replimune Group Inc. REPL Levitsky Hyam
Director
25,200 $0 25,200
(Direct)
View
2022-04-01
Option Award
2022-04-05
4:08 pm
N/A
2032-04-01
Replimune Group Inc. REPL Levitsky Hyam
Director
16,500 $0 16,500
(Direct)
View
2022-01-25
Option Award
2022-01-27
4:50 pm
N/A
2032-01-25
Century Therapeutics Inc. IPSC Levitsky Hyam
President of R&D
105,000 $0 105,000
(Direct)
View

Ownership
2021-06-17
4:59 pm
N/A
N/A
Century Therapeutics Inc. IPSC Levitsky Hyam
President of R&D
0 $0 556,416
(Indirect)
View
2021-04-01
Option Award
2021-04-05
8:15 pm
N/A
2031-04-01
Replimune Group Inc. REPL Levitsky Hyam
Director
16,500 $0 16,500
(Direct)
View